Nong Xu, MD

Professor Nong Xu, MD
 

Department of Medical Oncology
The First Affiliated Hospital, School of Medicine
Zhejiang University
Hangzhou, China

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)? Video

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)?
Professor Nong Xu, MD

Professor Nong Xu, MD

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE? Video

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE?

What kind of clinical samples are required to implement next generation sequencing (NGS)? Can NGS be applied to samples other than FFPE?
Professor Nong Xu, MD

Professor Nong Xu, MD

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment? Video

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment?

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment? For assessment of tumors in patients who have relapsed?
Professor Nong Xu, MD

Professor Nong Xu, MD